The Patent Finder

Laboratorios Farmaceuticos Rovi, S.A.

31 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 8 name spellings.

1
Ending by 2030
Nov 2026
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Jan 2 to 16, 2027 · next Jan 2
  • 4 fees due Mar 12 to 19, 2027 · next Mar 12
  • 2 fees due May 5 to 28, 2027 · next May 5
  • 1 fee due Sep 5, 2027
    The maintenance fee for Injectable composition with aromatase inhibitor (US 11,918,682) comes due Sep 5, 2027. Unpaid by Mar 6, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,820,202Extended release particle dispersion
In force
 · USPTO record
In forceUSPTO record
US 10,058,504Methods for the Preparation of Injectable Depot Compositions
In force
 · High confidence
In forceHigh confidence
US 10,085,936Antipsychotic injectable depot composition
In force
 · USPTO record
In forceUSPTO record
US 10,182,982Antipsychotic Injectable Depot Composition
In force
 · Medium confidence
In forceMedium confidence
US 10,195,138Methods for the Preparation of Injectable Depot Compositions
In force
 · Medium confidence
In forceMedium confidence
US 10,285,936Injectable composition with aromatase inhibitor
In force
 · USPTO record
In forceUSPTO record
US 10,335,366Risperidone or paliperidone implant formulation
In force
 · USPTO record
In forceUSPTO record
US 10,350,159Paliperidone implant formulation
In force
 · USPTO record
In forceUSPTO record
US 10,463,607Antipsychotic Injectable Depot Composition
In force
 · USPTO record
In forceUSPTO record
US 10,881,605Methods for the preparation of injectable depot compositions
In force
 · USPTO record
In forceUSPTO record
10 of 31 patents shown.
Pro members see all 31.
Pro members: see all 31 patents
Also on record, not counted in the 31: 7 lapsed for an unpaid fee · 4 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 1 abandoned · 5 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited